Proximal spinal muscular atrophy 5q

Proximal spinal muscular atrophy 5q

.

Bibliographic Details
Main Author:	article Editorial
Format:	Article
Language:	Russian
Published:	ABV-press 2020-12-01
Series:	Нервно-мышечные болезни
Online Access:	https://nmb.abvpress.ru/jour/article/view/408

Similar Items

Experience of Nusinersen in children with proximal spinal muscular atrophy 5q in Moscow region
by: M. V. Panteleeva
Published: (2022-12-01)

Diagnostic criteria for spinal muscular atrophy 5q
by: I. V. Sharkova, et al.
Published: (2021-12-01)

Adult-onset non-5q proximal spinal muscular atrophy: a comprehensive review
by: Wladimir Bocca Vieira de Rezende Pinto, et al.
Published: (2021-01-01)

Nusinersen Wearing-Off in Adult 5q-Spinal Muscular Atrophy Patients
by: Alma Osmanovic, et al.
Published: (2021-03-01)

Cognitive Impairment in Adult Patients with 5q-Associated Spinal Muscular Atrophy
by: Kathrin Kizina, et al.
Published: (2021-09-01)

Spinal muscular atrophy.
by: Talbot, K, et al.
Published: (2001)

Proximal spinal muscular atrophy 5q in the Republic of North Ossetia – Alania: population-genetic features, diagnostic problems and treatment prospects
by: I. S. Tebieva, et al.
Published: (2022-06-01)

Pilot Program of Newborn Screening for 5q Spinal Muscular Atrophy in the Russian Federation
by: Kristina Mikhalchuk, et al.
Published: (2023-05-01)

Spinal Muscular Atrophy 5q under the Mask of Myopathy: 10 Clinical Cases
by: Sergei A. Kurbatov
Published: (2021-12-01)

Improvement of muscle strength in specific muscular regions in nusinersen-treated adult patients with 5q-spinal muscular atrophy
by: Olivia Schreiber-Katz, et al.
Published: (2023-04-01)

Cognitive Performance of Patients with Adult 5q-Spinal Muscular Atrophy and with Amyotrophic Lateral Sclerosis
by: Alma Osmanovic, et al.
Published: (2020-12-01)

Rehabilitation in spinal muscular atrophy
by: Agus Iwan Foead, et al.
Published: (2019-01-01)

Rehabilitation in spinal muscular atrophy
by: Joanna Iłżecka
Published: (2021-05-01)

Troponin T is elevated in a relevant proportion of patients with 5q-associated spinal muscular atrophy
by: Hanna Sophie Lapp, et al.
Published: (2024-03-01)

Characteristics of genetic changes in the <i>SMN1</i> gene in spinal muscular atrophy 5q
by: A. V. Dil, et al.
Published: (2022-09-01)

Mapping of retrotransposon sequences in the unstable region surrounding the spinal muscular atrophy locus in 5q13.
by: Francis, M, et al.
Published: (1995)

A contig of non-chimaeric YACs containing the spinal muscular atrophy gene in 5q13.
by: Francis, M, et al.
Published: (1993)

Oral risdiplam for specific therapy in adult patients with 5q spinal muscular atrophy in the Moscow region
by: Ekaterina S. Novikova
Published: (2023-09-01)

Cerebrospinal Fluid Parameters in Antisense Oligonucleotide-Treated Adult 5q-Spinal Muscular Atrophy Patients
by: Lars Hendrik Müschen, et al.
Published: (2021-02-01)

Modeling spinal muscular atrophy in Drosophila.
by: Chang, H, et al.
Published: (2008)

Chapter 16 Spinal Muscular Atrophy
by: Talbot, K, et al.
Published: (2003)

Metabolic Dysfunction in Spinal Muscular Atrophy
by: Marc-Olivier Deguise, et al.
Published: (2021-05-01)

Mitochondrial Dysfunction in Spinal Muscular Atrophy
by: Eleonora Zilio, et al.
Published: (2022-09-01)

Editorial: Advances in spinal muscular atrophy
by: Jianli Sun
Published: (2023-03-01)

Spinal Muscular Atrophy With Myoclonic Epilepsy
by: Buket ÖZKARA, et al.
Published: (2017-04-01)

Proximal spinal muscular atrophy types I-IV: Specific features of molecular genetic diagnosis
by: V. V. Zabnenkova, et al.
Published: (2015-02-01)

Spinal muscular atrophy: a perspective outlook
by: M. R. Shaimurzin, et al.
Published: (2020-12-01)

Clinical and biochemical polymorphism of spinal muscular atrophy
by: M. G. Sokolova, et al.
Published: (2017-03-01)

Splice-switching therapy for spinal muscular atrophy.
by: Meijboom, K, et al.
Published: (2017)

Advances and limitations for the treatment of spinal muscular atrophy
by: John W. Day, et al.
Published: (2022-11-01)

Neurophysiological Characteristics in Type II and Type III 5q Spinal Muscular Atrophy Patients: Impact of Nusinersen Treatment
by: Li D, et al.
Published: (2024-03-01)

Adult spinal muscular atrophy: problems of early diagnosis
by: Yu. A. Shpilyukova, et al.
Published: (2022-12-01)

The social-economic burden of spinal muscular atrophy in Russia
by: A. S. Kolbin, et al.
Published: (2021-02-01)

Metabolic and Nutritional Issues Associated with Spinal Muscular Atrophy
by: Yang-Jean Li, et al.
Published: (2020-12-01)

Spinal muscular atrophy at the crossroads of basic science and therapy.
by: Sleigh, J, et al.
Published: (2013)

Spinal muscular atrophy at the crossroads of basic science and therapy
by: Sleigh, J, et al.
Published: (2013)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Bowerman, M, et al.
Published: (2017)

Therapeutic strategies for spinal muscular atrophy: SMN and beyond
by: Bowerman, M, et al.
Published: (2017)

Spinal muscular atrophy: disease mechanisms and therapeutic approaches
by: Meijboom, K
Published: (2018)

Infantile spinal muscular atrophy: Therapeutic (R)evolution
by: Daron, A, et al.
Published: (2019)